Plasma sCD14 as a Biomarker to Predict Pulmonary Exacerbations in Cystic Fibrosis

BACKGROUND: One in four cystic fibrosis (CF) patients diagnosed with a pulmonary exacerbation will not recover their baseline lung function despite standard treatment. This highlights the importance of preventing such events. Clinical decision-making can be improved through a simple blood test that...

Descripción completa

Detalles Bibliográficos
Autores principales: Quon, Bradley S., Ngan, David A., Wilcox, Pearce G., Man, S. F. Paul, Sin, Don D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3930718/
https://www.ncbi.nlm.nih.gov/pubmed/24586701
http://dx.doi.org/10.1371/journal.pone.0089341

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3930718/
https://www.ncbi.nlm.nih.gov/pubmed/24586701
http://dx.doi.org/10.1371/journal.pone.0089341

Ejemplares similares